Sign in

CIK 0001468929

  • Emerging growth company

NEXGEL, INC.

Sign in to watch
Ticker
NXGL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264042544
Phone
+1 215-702-8550
Business address
2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
Former names
NEXGEL, INC., AquaMed Technologies, Inc.

Securities

  • NXGL Common Stock Nasdaq
  • NXGLW Warrant Nasdaq
  1. 4 Open-market buy Director bought 11,848 shares at $2.11 ($24,999)
  2. 4 Open-market buy Chief Financial Officer bought 47,394 shares at $2.11 ($100,001)
  3. 4 Open-market buy Director bought 3,885 shares at $2.20 ($8,535)
  4. 4 Open-market buy Director bought 2,500 shares at $1.96 ($4,900)
  5. 4 Open-market buy Director bought 10,500 shares at an average $2.26 ($23,750)
  6. 4 Open-market buy Director bought 2,980 shares at an average $1.94 ($5,782)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 3,558 shares at $2.24 ($7,984)
  14. 4 Open-market buy Director bought 10,000 shares at an average $2.49 ($24,850)
  15. 4 Open-market buy Director bought 3,000 shares at an average $2.41 ($7,220)
  16. 4 Open-market buy Director bought 3,000 shares at an average $2.35 ($7,050)
  17. 4 Open-market buy Director bought 7,000 shares at an average $2.50 ($17,490)
  18. 4 Open-market buy Director bought 4,200 shares at $2.38 ($9,996)
  19. 4 Open-market buy Director bought 5,000 shares at $2.34 ($11,689)
  20. 4 Open-market buy Director bought 7,000 shares at an average $1.96 ($13,720)

Page 4 of 6 · 115 filings